Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Abstract
All alkalinization studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchAlkalinizationAlkalinization (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Sodium Bicarbonate Nebulized Therapy in Patients with Confirmed COVID-19

Rashedi et al., Advanced Pharmaceutical Bulletin, doi:10.34172/apb.2021.047
Oct 2020  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
27th treatment shown to reduce risk in November 2021
 
*, now with p = 0.0000000046 from 14 studies.
No treatment is 100% effective. Protocols combine treatments. * >10% efficacy, ≥3 studies.
4,500+ studies for 81 treatments. c19early.org
Proposal for nebulized sodium bicarbonate therapy for prevention of SARS-CoV-2 infection by raising endosomal pH and inhibiting viral entry into cells. Author proposes that inhalation of nebulized sodium bicarbonate solution (<5%) several times per day by COVID-19 patients may stop viral fusion and uncoating stages. Author notes that prospective controlled trials are needed.
See Mir et al. for another review covering alkalinization for COVID-19.
Rashedi et al., 14 Oct 2020, peer-reviewed, 3 authors.
This PaperAlkalinizationAll
Sodium Bicarbonate Nebulized Therapy in Patients with Confirmed COVID-19
Behroz Jalil Rashedi, Behroz Mahdavi Poor, Mohammad Asgharzadeh
Advanced Pharmaceutical Bulletin, doi:10.34172/apb.2021.047
replication phase will also remain barren and eventually the respiratory infection will be controlled. Prospective controlled trials are needed to evaluate this method efficacy.
Ethical Issues Not applicable. Conflict of Interest The authors declare that there is no conflict of interests.
References
Belouzard, Millet, Licitra, Whittaker, None
Hofmann, Pöhlmann, Cellular entry of the SARS coronavirus, Trends Microbiol, doi:10.1016/j.tim.2004.08.008
{ 'indexed': {'date-parts': [[2024, 2, 7]], 'date-time': '2024-02-07T21:01:14Z', 'timestamp': 1707339674306}, 'reference-count': 0, 'publisher': 'Maad Rayan Publishing Company', 'issue': '3', 'content-domain': {'domain': ['apb.tbzmed.ac.ir'], 'crossmark-restriction': False}, 'published-print': {'date-parts': [[2020, 10, 14]]}, 'DOI': '10.34172/apb.2021.047', 'type': 'journal-article', 'created': {'date-parts': [[2021, 7, 5]], 'date-time': '2021-07-05T15:12:03Z', 'timestamp': 1625497923000}, 'page': '397-398', 'update-policy': 'http://dx.doi.org/10.34172/crossmark_policy', 'source': 'Crossref', 'is-referenced-by-count': 2, 'title': 'Sodium Bicarbonate Nebulized Therapy in Patients with Confirmed COVID-19', 'prefix': '10.34172', 'volume': '11', 'author': [ { 'ORCID': 'http://orcid.org/0000-0002-9627-1491', 'authenticated-orcid': True, 'given': 'Jalil', 'family': 'Rashedi', 'sequence': 'first', 'affiliation': [ { 'name': 'Department of Laboratory Sciences, School of Paramedicine, ' 'Tabriz University of Medical Sciences, Tabriz, Iran.'}]}, { 'ORCID': 'http://orcid.org/0000-0002-8856-3750', 'authenticated-orcid': True, 'given': 'Behroz', 'family': 'Mahdavi Poor', 'sequence': 'additional', 'affiliation': [ { 'name': 'Department of Laboratory Sciences, School of Paramedicine, ' 'Tabriz University of Medical Sciences, Tabriz, Iran.'}]}, { 'ORCID': 'http://orcid.org/0000-0003-3386-4342', 'authenticated-orcid': True, 'given': 'Mohammad', 'family': 'Asgharzadeh', 'sequence': 'additional', 'affiliation': [ { 'name': 'Biotechnology Research Center, Tabriz University of Medical ' 'Sciences, Tabriz, Iran.'}]}], 'member': '20123', 'published-online': {'date-parts': [[2020, 10, 14]]}, 'container-title': 'Advanced Pharmaceutical Bulletin', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://apb.tbzmed.ac.ir/PDF/apb-11-397.pdf', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://apb.tbzmed.ac.ir/PDF/apb-11-397.pdf', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2021, 7, 5]], 'date-time': '2021-07-05T15:12:03Z', 'timestamp': 1625497923000}, 'score': 1, 'resource': {'primary': {'URL': 'https://apb.tbzmed.ac.ir/Article/apb-28931'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2020, 10, 14]]}, 'references-count': 0, 'journal-issue': {'issue': '3', 'published-online': {'date-parts': [[2021, 5]]}}, 'URL': 'http://dx.doi.org/10.34172/apb.2021.047', 'relation': {}, 'ISSN': ['2228-5881', '2251-7308'], 'subject': [], 'container-title-short': 'Adv Pharm Bull', 'published': {'date-parts': [[2020, 10, 14]]}, 'assertion': [ { 'value': 'Tabriz University of Medical Sciences', 'name': 'journal_owner', 'label': 'Journal Owner'}, { 'value': 'Tabriz University of Medical Sciences', 'name': 'journal_publisher', 'label': 'Journal Publisher'}, { 'value': '2020-05-09', 'order': 1, 'name': 'received', 'label': 'Received', 'group': {'name': 'publication_history', 'label': 'Publication History'}}, { 'value': '2020-10-14', 'order': 2, 'name': 'accepted', 'label': 'Accepted', 'group': {'name': 'publication_history', 'label': 'Publication History'}}, { 'value': '2020-10-14', 'order': 3, 'name': 'published', 'label': 'Published', 'group': {'name': 'publication_history', 'label': 'Publication History'}}]}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit